A federal court jury in Wilmington last week awarded Johnson & Johnson’s Lifescan Inc. unit more than $5.9 million after finding that Home Diagnostics Inc. and MIT Development Corp. infringed on a Lifescan patent for technology used in blood-sugar monitors.

After deliberating for a little more than eight hours, the five-woman, two-man jury on Friday awarded Lifescan the damages for lost royalties on technology the company said was used without permission by rivals Home Diagnostics and MIT.